Malignant Male Reproductive System Neoplasm Recruiting Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0071512 (Malignant Male Reproductive System Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01552434Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTreatment